Archive for 'Biotech products'

GlaxoSmithKline and Texas A&M approval to establish influenza vaccine facility

GlaxoSmithKline and Texas A&M approval to establish influenza vaccine facility

In March, GlaxoSmithKline(GSK) and the Texas A&M University System (TAMUS) announced the U.S. Department of Health and Human Services (DHHS) had approved the establishment of a $91 million (€70.3 million) influenza-vaccine manufacturing facility as the pillar [...]

UCB (Braine-l’Alleud, Belgium) and FivePrime Therapeutics (San Francisco, CA.) in collaboration for the discovery of innovative biologic targets and therapeutics

UCB (Braine-l’Alleud, Belgium) and FivePrime Therapeutics (San Francisco, CA.) in collaboration for the discovery of innovative biologic targets and therapeutics

UCB and Five Prime Therapeutics have recently entered a strategic collaboration for the discovery of innovative biologics targets and therapeutics for fibrosis-related inflammatory diseases and central nervous system (CNS) disorders.  UCB, located in the Wallonia region [...]

Human Waves (ULB, UMons) awarded prize for innovation at the Haute Ecole Condorcet (HEPH) “Talents de la Création” competition.

Human Waves (ULB, UMons) awarded prize for innovation at the Haute Ecole Condorcet (HEPH) “Talents de la Création” competition.

Human Waves has been awarded the prize for innovation at the Haute Ecole Condorcet (HEPH) “Talents de la Création” competition. On May 3rd, students of the 2nd Marketing BA of the HEPH announced the four prize-winners of the “Talents [...]

ZENTECH BIOTECHNOLOGY of Liège Science Park in Belgium is now incorporated in ASIA!

ZENTECH BIOTECHNOLOGY of Liège Science Park in Belgium is now incorporated in ASIA!

ZENTECH BIOTECHNOLOGY ASIA, based in Singapore, has recently been incorporated and has proudly announced that the implementation of its ASEAN strategy is well under way. Since 2006, ZenTech has targeted Asia and more specifically the ASEAN [...]

New developments further strengthen Bone Therapeutics’ cell product manufacturing capabilities

New developments further strengthen Bone Therapeutics’ cell product manufacturing capabilities

Updating on the February 15th post, some exciting new developments have recently occurred that further strengthen Bone Therapeutics’ cell product manufacturing capabilities. Following a successful Series D fundraising round, Bone Therapeutics, alongside the Walloon Region and private [...]

Mithra pharmaceuticals: making the most of its Belgian homeland with new Liège investment and creation of 160 jobs

Mithra pharmaceuticals: making the most of its Belgian homeland with new Liège investment and creation of 160 jobs

François Fornieri, founder and CEO of Mithra Pharmaceuticals and former manager of the year in 2011(Trends-Tendances), recently announced he will be making an important €40-50 million long-term investment in Liège that is expected to create 160 [...]

DNAlytics, a Belgian-based SME, introduces new diagnostic solution to help rheumatologists and orthopedic surgeons identify rheumatoid arthritis at the early onset

DNAlytics, a Belgian-based SME, introduces new diagnostic solution to help rheumatologists and orthopedic surgeons identify rheumatoid arthritis at the early onset

In keeping in line with their intent to develop a culture of innovation with a focus on the patient; and to be the reference partner in data analysis for predictive and personalized medicine for the European [...]

CluePoints holds official inauguration* of new office in Mont Saint Guibert and launches solution for risk-based monitoring using the SMART™ engine approach

CluePoints holds official inauguration* of new office in Mont Saint Guibert and launches solution for risk-based monitoring using the SMART™ engine approach

IDDI (International Drug Development Institute) has recently launched its subsidiary entitled CluePoints, the new software and service provider of Intelligent Statistical Monitoring Solutions. This exciting new development is a follow-up to the IDDI article published last [...]

Artialis’ biomarker technology provides early detection of joint disorders and effective monitoring of treatments, confirming Tilman’s plant based supplement offers effective treatment

Artialis’ biomarker technology provides early detection of joint disorders and effective monitoring of treatments, confirming Tilman’s plant based supplement offers effective treatment

Artialis(Liège) and Tilman(Baillonville), two Wallonia-based biotech companies specialized in joint disorders and medicinal plant therapy respectively, through combined efforts are making a name for themeselves with effective “natural” treatment of joint disorders. Everyone knows joints can [...]

Cardiatis (Isnes, Belgium) creates multilayer flow modulator stent offering non-invasive alternative for the treatment of a “Silent Killer”

Cardiatis (Isnes, Belgium) creates multilayer flow modulator stent offering non-invasive alternative for the treatment of a “Silent Killer”

Stemming from the idea of the continuous flow of jet induced fountains, Cardiatis CEO, Noureddine Frid, imagined that if the theory of “fluid mechanics” could be applied to converting turbulence to laminar flow in the blood [...]

« Previous
Newer »